|
EPRS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.583400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.704600E-01 |
| Normal-vs-Stage2 |
7.780800E-01 |
| Normal-vs-Stage3 |
1.633350E-01 |
| Normal-vs-Stage4 |
6.345000E-01 |
| Stage1-vs-Stage2 |
8.446600E-01 |
| Stage1-vs-Stage3 |
4.079200E-01 |
| Stage1-vs-Stage4 |
2.976000E-01 |
| Stage2-vs-Stage3 |
4.315800E-01 |
| Stage2-vs-Stage4 |
5.331800E-01 |
| Stage3-vs-Stage4 |
1.588430E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.431200E-01 |
| Normal-vs-AfricanAmerican |
5.300200E-01 |
| Normal-vs-Asian |
8.990000E-01 |
| Caucasian-vs-AfricanAmerican |
2.580200E-01 |
| Caucasian-vs-Asian |
6.022400E-01 |
| AfricanAmerican-vs-Asian |
4.871600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.370370E-01 |
| Normal-vs-Female |
7.441800E-01 |
| Male-vs-Female |
1.526430E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.694800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.464580E-01 |
| Normal-vs-Age(61-80Yrs) |
9.080000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.739200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.070000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.213800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.909600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.737020E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.171800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.864590E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.469800E-01 |
| Classical-VS-Follicular |
7.240500E-04 |
| Classical-VS-Other |
5.067800E-02 |
| Classical-VS-Normal |
6.312000E-01 |
| Tall-VS-Follicular |
1.361640E-01 |
| Tall-VS-Other |
5.635900E-02 |
| Tall-VS-Normal |
7.152200E-01 |
| Follicular-VS-Other |
4.328600E-01 |
| Follicular-VS-Normal |
1.287960E-02 |
| Other-VS-Normal |
1.313650E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.525430E-01 |
| Normal-vs-N1 |
5.486300E-02 |
| N0-vs-N1 |
3.501800E-01 |
|
|
